Sentimag biopsija limfnog čvora stražara u konzervativnoj kirurgiji dojke – preliminarni rezultati
Ilija Guteša
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ivana Potesak
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ivana Pavičić
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Gordan Tometić
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Iva Kirac
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ivan Penavić
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ivan Milas
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Mladen Stanec
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
APA 6th Edition Guteša, I., Potesak, I., Pavičić, I., Tometić, G., Kirac, I., Penavić, I., ... Stanec, M. (2016). Sentimag sentinel lymph node biopsy in breast conservative surgery – preliminary results. Libri Oncologici, 44 (2-3), 15-19. Preuzeto s https://hrcak.srce.hr/177104
MLA 8th Edition Guteša, Ilija, et al. "Sentimag sentinel lymph node biopsy in breast conservative surgery – preliminary results." Libri Oncologici, vol. 44, br. 2-3, 2016, str. 15-19. https://hrcak.srce.hr/177104. Citirano 27.01.2021.
Chicago 17th Edition Guteša, Ilija, Ivana Potesak, Ivana Pavičić, Gordan Tometić, Iva Kirac, Ivan Penavić, Ivan Milas i Mladen Stanec. "Sentimag sentinel lymph node biopsy in breast conservative surgery – preliminary results." Libri Oncologici 44, br. 2-3 (2016): 15-19. https://hrcak.srce.hr/177104
Harvard Guteša, I., et al. (2016). 'Sentimag sentinel lymph node biopsy in breast conservative surgery – preliminary results', Libri Oncologici, 44(2-3), str. 15-19. Preuzeto s: https://hrcak.srce.hr/177104 (Datum pristupa: 27.01.2021.)
Vancouver Guteša I, Potesak I, Pavičić I, Tometić G, Kirac I, Penavić I i sur. Sentimag sentinel lymph node biopsy in breast conservative surgery – preliminary results. Libri Oncologici [Internet]. 2016 [pristupljeno 27.01.2021.];44(2-3):15-19. Dostupno na: https://hrcak.srce.hr/177104
IEEE I. Guteša, et al., "Sentimag sentinel lymph node biopsy in breast conservative surgery – preliminary results", Libri Oncologici, vol.44, br. 2-3, str. 15-19, 2016. [Online]. Dostupno na: https://hrcak.srce.hr/177104. [Citirano: 27.01.2021.]
Sažetak Segmentektomija i biopsija limfnog čvora stražara zlatni su standard za kirurško liječenje ranog raka dojke (klinički i radiološki cT1-2, c N0). Čestice superparamagnetskog željeznog oksida (superparamagnetic iron oxide, SPIO) od nedavno se
koriste kao unutaroperacijski nanočestični obilježivač. Prospektivno smo bilježili demografske podatke o bolesnicama, histologiju tumora te označenih i neoznačenih limfnih čvorova. U 128 bolesnica učinjena je biopsija limfnog čvora stražara u aksili detektorom SentiMag. Tri bolesnice su isključene, jer je konačan patohistoloski nalaz bio carcinoma ductale in situ (DCIS). Limfni čvor je pronađen u 119 od 125 bolesnica (95.2%), pozitivne limfne čvorove su imale 24 (19.2%), makrometasaze 2 (1.6%) i mikrometastaze 1 bolesnica (0.08%). Od 30 pozitivnih odstranjenih limfnih čvorava, obilježenih je bilo 24 (80
%). Prosječno su po bolesnici izvađena 2.3 limfna čvora. Mogućnost otkrivanja limfnog čvora stražara SentiMagom usporediva je s dosad objavljenim podatcima i zlatnim standardom. Prednosti metode su lakše rukovanje i minimalna logistika.